| Ticker: | GPCR |
| Current Price: | $20.00 |
| % Daily Change: | 0.81% |
| Volume (1,000s): | 1,345.86 |
| Average Volume (1,000s): | 793.97 |
| Market Cap (M): | $1,151.33 |
| 1/2/2024 Price: | $40.76 |
| Change Since Inception: | -50.93% |
Structure Therapeutics Inc.
601 Gateway Boulevard
Suite 900
South San Francisco, CA 94080
United States
Structure Therapeutics creates life-changing medicines for patients using advanced computational and structure-based technology. Our platform combines the latest advancements in computational chemistry, visualization of molecular interactions, and data integration to design orally available, superior medicines that overcome current limitations in biologic and peptide drugs. We are advancing our clinical-stage pipeline of differentiated, efficacious and safe treatments focused on chronic diseases with high unmet need, including cardiovascular, metabolic and pulmonary conditions. At Structure, our team’s deep experience with complex biological targets and mechanisms, structure-based drug design, and global drug discovery and development enables our bold vision: to design and develop world-class medicines with tremendous patient impact and broad commercial opportunity.